Jubilant Therapeutics Inc., a biopharmaceutical company advancing small molecule precision therapeutics to address unmet medical needs in oncology and autoimmune diseases, today announced the dosing ...
Stem, Inc. ( (STEM)) has realeased its Q3 earnings. Here is a breakdown of the information Stem, Inc. presented to its investors. Stem, Inc. is a global leader in artificial intelligence-driven ...
Stem cells grown in microgravity aboard the International Space Station (ISS) have unique qualities that could one day help accelerate new biotherapies and heal complex disease, two Mayo Clinic ...
Stem, Inc. (STEM) has disclosed a new risk, in the Share Price & Shareholder Rights category. Stem, Inc. faces a significant risk of failing to meet the NYSE’s continued listing criteria as its ...
For the first time, scientists have tracked what happens to stem cells decades after a transplant, lifting the lid on the procedure that has been a medical mystery for over 50 years. Insights ...
23andMe has appointed three new independent directors to its board following the mass resignation of all seven of its previous members last month. The biotech company said in an SEC filing that ...
5d
DelveInsight's 'Exosomes Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and ...
The European Chips Skills Academy (ECSA), an EU-funded initiative coordinated by SEMI, today announced the publication of the Skills ...
The global steam trap market is expected to be USD 5.57 billion by 2029 from USD 4.57 billion by 2024, at a CAGR of 4.1% ...
The Artificial Intelligence in Retail Market is expected to reach USD 164.74 billion by 2030 from USD 31.12 billion in 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
